User profiles for A. Brog
Åke BorgDepartment of Oncology, Clinical Sciences, Lund University, Sweden Verified email at med.lu.se Cited by 81458 |
[PDF][PDF] Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families
…, D Stoppa-Lyonnet, Y Bignon, A Borg… - The American Journal of …, 1998 - cell.com
The contribution of BRCA1 and BRCA2 to inherited breast cancer was assessed by linkage
and mutation analysis in 237 families, each with at least four cases of breast cancer, …
and mutation analysis in 237 families, each with at least four cases of breast cancer, …
Signatures of mutational processes in human cancer
All cancers are caused by somatic mutations; however, understanding of the biological
processes generating these mutations is limited. The catalogue of somatic mutations from a …
processes generating these mutations is limited. The catalogue of somatic mutations from a …
[HTML][HTML] Mutational processes molding the genomes of 21 breast cancers
All cancers carry somatic mutations. The patterns of mutation in cancer genomes reflect the
DNA damage and repair processes to which cancer cells and their precursors have been …
DNA damage and repair processes to which cancer cells and their precursors have been …
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
We analysed whole-genome sequences of 560 breast cancers to advance understanding of
the driver mutations conferring clonal advantage and the mutational processes generating …
the driver mutations conferring clonal advantage and the mutational processes generating …
[HTML][HTML] The life history of 21 breast cancers
Cancer evolves dynamically as clonal expansions supersede one another driven by shifting
selective pressures, mutational processes, and disrupted cancer genes. These processes …
selective pressures, mutational processes, and disrupted cancer genes. These processes …
[HTML][HTML] Gene-expression profiles in hereditary breast cancer
…, G Sauter, OP Kallioniemi, Å Borg… - … England Journal of …, 2001 - Mass Medical Soc
Background Many cases of hereditary breast cancer are due to mutations in either the
BRCA1 or the BRCA2 gene. The histopathological changes in these cancers are often …
BRCA1 or the BRCA2 gene. The histopathological changes in these cancers are often …
Visualization and analysis of gene expression in tissue sections by spatial transcriptomics
Analysis of the pattern of proteins or messengerRNAs (mRNAs) in histological tissue
sections is a cornerstone in biomedical research and diagnostics. This typically involves the …
sections is a cornerstone in biomedical research and diagnostics. This typically involves the …
[PDF][PDF] Recruitment of HIF-1α and HIF-2α to common target genes is differentially regulated in neuroblastoma: HIF-2α promotes an aggressive phenotype
In neuroblastoma specimens, HIF-2α but not HIF-1α is strongly expressed in well-vascularized
areas. In vitro, HIF-2α protein was stabilized at 5% O 2 (resembling end capillary oxygen …
areas. In vitro, HIF-2α protein was stabilized at 5% O 2 (resembling end capillary oxygen …
[HTML][HTML] Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts
Y Pawitan, J Bjöhle, L Amler, AL Borg, S Egyhazi… - Breast cancer …, 2005 - Springer
Introduction Adjuvant breast cancer therapy significantly improves survival, but overtreatment
and undertreatment are major problems. Breast cancer expression profiling has so far …
and undertreatment are major problems. Breast cancer expression profiling has so far …
PIK3CA Mutations Correlate with Hormone Receptors, Node Metastasis, and ERBB2, and Are Mutually Exclusive with PTEN Loss in Human Breast Carcinoma
…, M Mansukhani, J Enoksson, H Hibshoosh, A Borg… - Cancer research, 2005 - AACR
Deregulation of the phosphatidylinositol 3-kinase (PI3K) pathway either through loss of PTEN
or mutation of the catalytic subunit α of PI3K (PIK3CA) occurs frequently in human cancer. …
or mutation of the catalytic subunit α of PI3K (PIK3CA) occurs frequently in human cancer. …